Study finds colchicine may be effective for treating gout Keryx enrolling patents in phase 3 trial for colorectal cancer drug iBio announces rights grant for anthrax-plague combination vaccine Peter Ciano named Tris Pharma's VP corporate development Armada Health Care gears up for 2010 Specialty Pharmacy Summit Decision Resources: Ovarian cancer drug market to triple Qutenza now available as shingles treatment Par reaches settlement with Sanofi-Aventis for Eloxatin generic Keryx's cancer drug gets fast-track designation from FDA MDRNA to buy Cequent Pharmaceuticals First Previous 201 202 203 204 205 Next Last